scispace - formally typeset
J

Jianfeng Wu

Researcher at University of California, San Francisco

Publications -  11
Citations -  3329

Jianfeng Wu is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Integrin & Vitronectin. The author has an hindex of 9, co-authored 10 publications receiving 3158 citations.

Papers
More filters
Journal ArticleDOI

The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis.

TL;DR: In this article, Latency-Aged Peptide (LAP) was shown to be a ligand for the integrin alpha v beta 6 and that alpha-v beta 6-expressing cells induce spatially restricted activation of TGF beta 1.
Journal ArticleDOI

Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin.

TL;DR: Results suggest that the epithelial integrin alpha v beta 6 participates in the modulation of epithelial inflammation, and genetic or acquired alterations in this integrin could contribute to the development of inflammatory diseases of epithel organs, such as the lungs and skin.
Journal ArticleDOI

Fatal Bilateral Chylothorax in Mice Lacking the Integrin α9β1

TL;DR: The results suggest that the α9 integrin is required for the normal development of the lymphatic system, including the thoracic duct, and that α9 deficiency could be one cause of congenital chylothorax.
Journal ArticleDOI

Normal Development, Wound Healing, and Adenovirus Susceptibility in β5-Deficient Mice

TL;DR: The data suggest that αvβ5 is not essential for normal development, reproduction, adenovirus infection, or the healing of cutaneous wounds.
Journal ArticleDOI

The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin

TL;DR: Alphav beta6-mediated migration on both ligands was dramatically augmented by treatment with phorbol myrisate acetate (PMA) or with hepatocyte growth factor, and augmentation of migration by either stimulus could be abolished by the PKC inhibitor GF109203X, suggesting a critical role for PKC in enhancement of alphavbeta6- mediated cell migration.